Haemonetics Corporation

Financials

Total de ativos 2.45 B2.46 B2.44 B2.49 B Total de passivos 1.68 B1.58 B1.59 B1.58 B Capital total 820.84 M882.3 M849.17 M911.45 M Total de passivos e patrimônio líquido 2.45 B2.46 B2.44 B2.49 B Dívida total 1.22 B1.22 B1.22 B1.22 B Dívida líquida 918.02 M931.88 M928.3 M861.37 M

Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen Latham in the 1970s. Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas.

HAE

Financials

Haemonetics Corporation

Notícias

Haemonetics recebe aprovação da FDA para uso expandido de sistema de fechamento vascular

BTIG mantém recomendação de compra para Haemonetics após expansão de indicação aprovada pela FDA

QUEM AVISA, AMIGO É: Assine InvestingPro com um super desconto na Oferta Relâmpago

FLASH SALE: Get your InvestingPro subscription for LOWEST PRICE of the year NOW

PROMOÇÃO RELÂMPAGO: Assine o InvestingPro pelo MENOR PREÇO do ano AGORA

Why Is Zimmer (ZBH) Down 2% Since Last Earnings Report?

Is it Apt to Retain Haemonetics Stock in Your Portfolio for Now?

Royce Premier Fund FY 2025: What Worked… And What Didn’t

Allspring Special Small Cap Value Fund Q4 2025 Portfolio Review

Haemonetics reembolsa US$ 300 milhões em notas conversíveis no vencimento

Haemonetics repays $300 million convertible notes at maturity

Haemonetics na Raymond James: crescimento estratégico e desafios